The success of GLP-1 receptor agonists/analogues has transformed metabolic disease treatment while demonstrating the potential of engineered peptides to deliver long-acting, highly targeted therapies.

Reach customers where they live, work, and scroll. With 665,386 unique visits in the past 28 days alone, timesleader.com stands as one of the most highly trafficked websites in Northeastern ...

Morgan Stanley executive denies Wall Street acts on crypto FOMO. Banks shift from cautious exposure to broader crypto and infrastructure strategies. Morgan Stanley plans to support tokenized equities ...